Psoriasis is a chronic immune-driven condition, but with the right combination of treatments and lifestyle adjustments, most people can keep flares under control and achieve significant skin clearing. Management depends on severity: mild cases often respond to topical treatments alone, moderate-to-severe cases may need phototherapy, oral medications, or injectable biologics. The best approach usually layers several strategies together.
What’s Happening in Your Skin
In healthy skin, cells move from the deepest layer to the surface over about 37 days, then shed invisibly. In psoriasis, the immune system drives that process into overdrive: skin cells reach the surface in just 4 to 5 days. They pile up faster than they can shed, forming the thick, scaly plaques that define the condition. This isn’t a skin-care problem you can moisturize away. It’s an immune system that’s sending constant “grow and inflame” signals to your skin cells.
Understanding this helps explain why effective treatments either calm the immune response, slow cell growth, or both.
Topical Treatments for Mild to Moderate Psoriasis
Topical corticosteroids are the most commonly prescribed first-line treatment. They come in seven potency classes in the U.S., from superpotent (class I) down to least potent (class VII, which includes over-the-counter hydrocortisone). Your doctor will match the potency to the location and thickness of your plaques. Thicker plaques on elbows and knees typically need higher-potency options, while sensitive areas like the face, groin, and armpits require lower-potency formulations to avoid skin thinning.
Regardless of potency, topical steroids generally shouldn’t be used continuously for more than 2 to 4 weeks. High-potency steroids are usually limited to 2 weeks before tapering down. Using them longer raises the risk of skin thinning, stretch marks, and rebound flares when you stop. Many dermatologists recommend a “pulse” approach: use the steroid for a few weeks, switch to a non-steroidal option, and rotate back as needed.
Vitamin D analogs (like calcipotriene) and retinoid creams are common steroid-sparing alternatives. They work differently, slowing skin cell turnover rather than suppressing inflammation, so they pair well with steroids in a rotation schedule. Moisturizers with ceramides or petrolatum won’t treat psoriasis directly, but keeping plaques hydrated reduces cracking, itching, and discomfort between treatment applications.
Managing Scalp Psoriasis
The scalp is one of the most common and frustrating locations for psoriasis. Thick scale buildup can make topical treatments less effective because the medication can’t reach the skin underneath. Medicated shampoos help break through that barrier. Coal tar shampoos containing 2 to 10% coal tar solution reduce inflammation and slow cell growth. Salicylic acid at 5 to 10% concentration acts as a keratolytic, meaning it softens and loosens scale so it can be washed away.
A practical approach is to use a salicylic acid shampoo first to remove scale, then follow with a prescription steroid solution or foam that can actually penetrate to the scalp. Leave medicated shampoos on for several minutes before rinsing to give the active ingredients time to work.
Phototherapy
When topical treatments aren’t enough, narrowband UVB phototherapy is often the next step. It works by slowing the rapid skin cell growth and dampening the local immune response. Treatment typically requires three sessions per week, with most patients needing 20 to 36 sessions to see significant improvement. That means roughly 7 to 12 weeks of consistent visits.
The commitment is real. To get meaningful results, you need to complete at least 20 sessions. Missing sessions or stopping early often means starting over. Phototherapy is available in dermatology offices, and some patients eventually use prescribed home units for maintenance. Side effects are generally mild: temporary redness and increased long-term sun sensitivity.
Oral Medications for Moderate to Severe Cases
When psoriasis covers a large body surface area or significantly affects quality of life, systemic medications become necessary. Methotrexate has been a mainstay for decades. It’s taken once weekly (not daily) and works by broadly suppressing the overactive immune response. The tradeoff is that it requires regular blood monitoring, especially liver function tests. During the first two months, blood work is typically drawn every 4 to 8 weeks. After six months, the interval can stretch to every 12 weeks if results are stable. People who are overweight or have risk factors for fatty liver disease may need additional monitoring, including imaging or even liver biopsy at certain cumulative doses.
A newer oral option is deucravacitinib, which works by selectively blocking a specific enzyme involved in the immune signaling cascade that drives psoriasis. About 60% of patients see significant improvement by 16 weeks, and results continue improving through 24 weeks and hold steady through at least two years of treatment. Its side effect profile is relatively favorable compared to older oral medications, with no boxed warnings, though it has been linked to small increases in herpes virus reactivation. A tuberculosis screening is recommended before starting, and patients at risk for high cholesterol should have their triglycerides monitored.
Biologic Therapies
Biologics are injectable or infused medications that target specific parts of the immune system rather than suppressing it broadly. Eleven biologic therapies are currently FDA-approved for psoriasis, and they fall into four classes based on what they block. Their effectiveness varies considerably.
In a network meta-analysis comparing the probability of achieving complete skin clearance, the newer classes outperformed older ones by a wide margin. IL-23 inhibitors led the field: risankizumab achieved complete clearance in about 61% of patients, and guselkumab in about 54%. IL-17 inhibitors were close behind, with brodalumab at roughly 55%, ixekizumab at 46%, and secukinumab at 41%. The older TNF-alpha inhibitors cleared skin completely in about 17 to 26% of patients.
These numbers represent complete clearance, not just improvement. Even patients who don’t achieve full clearance on a biologic often see dramatic reduction in plaques. Biologics are typically prescribed when topical treatments and phototherapy haven’t provided adequate control, or when psoriasis significantly impairs daily functioning. Most are self-injected at home every few weeks to months after an initial loading period, making them more convenient than phototherapy for many people.
Lifestyle Factors That Affect Flares
Smoking has a moderately strong correlation with psoriasis severity. One study found a correlation of 0.63 between cigarette smoking and PASI scores (a standard measure of psoriasis severity), meaning heavier smokers tended to have more severe disease. Quitting won’t cure psoriasis, but it removes a measurable driver of inflammation. Alcohol showed a weaker, statistically non-significant correlation with severity (0.32), though heavy drinking can still interfere with treatment effectiveness, particularly with methotrexate, which shares the liver as its processing pathway.
Excess body weight is another well-established trigger. Fat tissue produces inflammatory signaling molecules that feed the same immune pathways responsible for psoriasis. Weight loss, even modest amounts, has been shown to improve treatment response and reduce flare frequency. Regular physical activity helps both directly through anti-inflammatory effects and indirectly through weight management and stress reduction.
Stress is a common flare trigger. The mechanism is straightforward: psychological stress raises levels of stress hormones that amplify inflammatory immune activity. There’s no single stress-management technique that works for everyone, but consistent sleep, exercise, and some form of intentional relaxation (meditation, breathing exercises, therapy) all help reduce the frequency of stress-triggered flares.
Diet and Psoriasis
No single diet cures psoriasis, but specific dietary changes can help certain people. The strongest evidence involves gluten. About 16% of people with plaque psoriasis have antibodies to gliadin, a protein in gluten. In a study of patients who tested positive for these antibodies, a three-month gluten-free diet reduced markers of skin cell overproduction by 50% in affected skin. Importantly, this benefit was seen in psoriasis patients with gliadin antibodies, not in the general psoriasis population. A simple blood test can check for these antibodies and help you decide whether a gluten-free trial is worth attempting.
More broadly, an anti-inflammatory dietary pattern (rich in vegetables, fatty fish, olive oil, and nuts, with limited processed food, sugar, and red meat) aligns with the general goal of lowering systemic inflammation. It’s not a replacement for medical treatment, but it supports it.
Watching for Psoriatic Arthritis
Up to 30% of people with psoriasis eventually develop psoriatic arthritis, an inflammatory joint condition that can cause permanent damage if untreated. Joint symptoms can appear years after skin symptoms begin, or occasionally before any plaques show up. The warning signs to watch for include persistent joint pain or stiffness (especially in the morning or after sitting), swelling of an entire finger or toe (called dactylitis, or “sausage digit”), heel pain, or low back stiffness that improves with movement rather than rest.
Early detection matters because joint erosion from psoriatic arthritis is irreversible. If you notice any of these symptoms, bringing them up at your next dermatology or primary care visit can prompt a referral to a rheumatologist before damage accumulates.